Literature DB >> 2465525

Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.

M P Kamps1, B M Sefton.   

Abstract

The cellular transformation induced by viral tyrosine protein kinases may result from the excessive phosphorylation of the normal polypeptide substrates of endogenous cellular tyrosine kinases, from the phosphorylation of proteins that are not normal substrates of cellular tyrosine protein kinases in uninfected cells, or from the phosphorylation of proteins of each type. To differentiate between these possibilities, antibodies to phosphotyrosine were used with immunoblotting to compare the substrates of p60v-src, the transforming tyrosine protein kinase of Rous sarcoma virus (RSV), with those of cellular tyrosine protein kinases. Specifically, the substrates of p60v-src were compared with those of (1) p60c-src, (2) the tyrosine protein kinases activated by the binding of platelet-derived growth factor and (3) normal cellular tyrosine protein kinases in fibroblasts treated with sodium orthovanadate, an inhibitor of phosphatases. Comparison of the patterns observed on the immunoblots with the pattern of phosphotyrosine-containing proteins isolated by immunoaffinity chromatography with antiphosphotyrosine antibodies demonstrated that the proteins detected by Western blotting did indeed contain phosphotyrosine. Cells transformed by a variant of c-src activated by a single point mutation had an almost identical pattern of tyrosine protein phosphorylation as cells transformed by v-src. The several mutations and carboxyl-terminal substitution that differentiate p60v-src from p60c-src appear therefore to affect the enzymatic activity, but not the polypeptide substrate specificity, of the viral protein. In cells transformed by v-src, 27 of the 35 phosphotyrosine-containing proteins were also phosphorylated on tyrosine in normal uninfected fibroblasts treated with sodium orthovanadate. The phosphorylation of the large majority of the substrates of p60v-src can therefore occur in uninfected cells. Nine of the substrates of p60v-src were also phosphorylated by the viral tyrosine protein kinases encoded by the oncogenes, v-abl, v-fps, v-fes, and v-fgr. Together these data are consistent with the idea that viral tyrosine protein kinases induce transformation largely by intervening in cellular regulatory pathways that are normally controlled by tyrosine protein phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2465525

Source DB:  PubMed          Journal:  Oncogene Res        ISSN: 0890-6467


  14 in total

Review 1.  Regulation of gap junctions by tyrosine protein kinases.

Authors:  Bonnie J Warn-Cramer; Alan F Lau
Journal:  Biochim Biophys Acta       Date:  2004-03-23

2.  A myristylated form of the sea oncoprotein can transform chicken embryo fibroblasts.

Authors:  A J Crowe; M J Hayman
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Dissecting the activating mutations in v-erbB of avian erythroblastosis virus strain R.

Authors:  H K Shu; R J Pelley; H J Kung
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates.

Authors:  K Shah; Y Liu; C Deirmengian; K M Shokat
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Differential regulation of FGFR3 by PTPN1 and PTPN2.

Authors:  Jonathan R St-Germain; Paul Taylor; Wen Zhang; Zhihua Li; Troy Ketela; Jason Moffat; Benjamin G Neel; Suzanne Trudel; Michael F Moran
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

6.  Tyrosine phosphorylation of A17 during vaccinia virus infection: involvement of the H1 phosphatase and the F10 kinase.

Authors:  M Derrien; A Punjabi; M Khanna; O Grubisha; P Traktman
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

7.  Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibition.

Authors:  Jonathan R St-Germain; Paul Taylor; Jiefei Tong; Lily L Jin; Ana Nikolic; Ian I Stewart; Robert M Ewing; Moyez Dharsee; Zhihua Li; Suzanne Trudel; Michael F Moran
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

8.  Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.

Authors:  S M Jong; C S Zong; T Dorai; L H Wang
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

9.  Loss of transformed phenotype upon senescence of Rous sarcoma virus-infected chicken neuroretinal cells.

Authors:  G M Seigel; M F Notter
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  Disease specificity of kinase domains: the src-encoded catalytic domain converts erbB into a sarcoma oncogene.

Authors:  C M Chang; H K Shu; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.